These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 13789446)

  • 21. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
    MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative evaluation of human antipertussis vaccines of domestic production. III. Epidemiological evaluation of the pertussis component of diphtheria-tetanus-pertussis vaccines].
    ADONAJLO A; PIATKOWSKI J; DZIKOWSKA J; MAGDZIARZ H; GILEWSKA A
    Przegl Epidemiol; 1962; 16():423-30. PubMed ID: 14040955
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of routine immunization of children with triple vaccine (diphtheria-tetanus-pertussis).
    IPSEN J; BOWEN HE
    Am J Public Health Nations Health; 1955 Mar; 45(3):312-8. PubMed ID: 14350122
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunological effect of simultaneous administration of poliomyelitis and combined diphtheria-tetanus-pertussis vaccines. II. Effect of combined diphtheria-tetanus-pertussis vaccine on immunological activity of Sabin's monovalent poliomyelitis vaccine].
    KELEMEN G; MAROCZI J; PACSA S; RETHY L
    Orv Hetil; 1961 Feb; 102():249-50. PubMed ID: 13752245
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extensive swelling reaction associated with diphtheria and tetanus toxoids and acellular pertussis vaccine.
    Sekaran NK; Edwards KM
    Pediatr Infect Dis J; 2006 Apr; 25(4):374-5. PubMed ID: 16567996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COMBINED immunization against diphtheria tetanus pertussis.
    Squibb Memo; 1947 Sep; 26(3):4-7. PubMed ID: 20265420
    [No Abstract]   [Full Text] [Related]  

  • 29. [A comparative study of the reactogenicity of pertussis-diphtheria, pertussis-diphtheria-tetanus and adsorbed pertussis-diphtheria-tetanus vaccines].
    Sapozhnikov II; Dimova GV; Kotreleva NV; Turchanina AA; Shumova BI
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Feb; 43(2):22-7. PubMed ID: 6004848
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccinations on Reported Pertussis Cases Among Those 11 to 18 Years of Age in an Era of Waning Pertussis Immunity: A Follow-up Analysis.
    Skoff TH; Martin SW
    JAMA Pediatr; 2016 May; 170(5):453-8. PubMed ID: 27018748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.
    Sato H; Sato Y
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S124-30. PubMed ID: 10447030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
    Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
    Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Gothenburg pertussis vaccine study.
    Trollfors B; Taranger J
    Dev Biol Stand; 1997; 89():49-51. PubMed ID: 9333568
    [No Abstract]   [Full Text] [Related]  

  • 36. FACTORS INVOLVED IN THE STABILITY OF PERTUSSIS COMPONENT IN QUADRUPLE DPT-POLIO VACCINE.
    PONTECORVO M
    Riv Ist Sieroter Ital; 1964; 39():464-9. PubMed ID: 14259054
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypotonic hyporesponsive episodes in eight pertussis vaccine studies.
    Heijbel H; Ciofi degli Atti M; Harzer E; Liese J; Preziosi MP; Rasmussen F; Schmitt HJ; Storsaeter J; Taranger J; Uberall M; Tozzi AE
    Dev Biol Stand; 1997; 89():101-3. PubMed ID: 9272338
    [No Abstract]   [Full Text] [Related]  

  • 38. [A comparative study of the reactogenic properties and immunologic effectiveness of pertussis-diphtheria-tetanus and associated pertussis-diphtheria-tetanus vaccines. I. Immunologic effectiveness of the tetanus component in pertussis-diphtheria-tetanus and associated pertussis-diphtheria-tetanus vaccines].
    Baeva EA; Klimovitskaia VE; Sergeeva LM
    Zh Mikrobiol Epidemiol Immunobiol; 1967; 44(3):98-101. PubMed ID: 4894105
    [No Abstract]   [Full Text] [Related]  

  • 39. Active basal immunity and its application to epidemiology. IV. Initial pain in diphtheria-tetanus-pertussis vaccination.
    HESSELVIK L; ERICSSON H
    Acta Paediatr (Stockh); 1954 Jan; 43(1):22-6. PubMed ID: 13138171
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy trial of acellular pertussis vaccines; trial I.
    Olin P
    Dev Biol Stand; 1997; 89():52-4. PubMed ID: 9333569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.